Antimuscarinic treatment in overactive bladder: special considerations in elderly patients.
Overactive bladder is a common condition that increases in prevalence in association with age. Antimuscarinic therapy remains the mainstay of pharmacological treatment for the condition, and there is an increasing body of evidence that supports the use of these drugs. Despite this, and because of concerns about associated adverse effects, older people are less likely to receive active treatment for their condition. This review considers some of the factors that need to be taken into account when using these medications.
Division of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada. Adrian.wagg@ualberta.ca
Adrian S
AS
Wagg
D000368:Aged; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D006801:Humans; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D019338:Polypharmacy; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000503:physiopathology
D018727:Muscarinic Antagonists